Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 7, 2024Clinical & Translational OncologyOpen Access

Variation of peripheral blood-based biomarkers for response of anti-PD-1 immunotherapy in non-small-cell lung cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

XWXiaoming WangWannan Medical CollegeDCDayu ChenNanjing Drum Tower HospitalYMYuyan MaQilu Hospital of Shandong University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wang et al. (2024) studied this question.

synapsesocial.com/papers/68e75433b6db6435876cc24chttps://doi.org/10.1007/s12094-024-03416-5
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Plasma IL-6 changes correlate to PD-1 inhibitor responses in NSCLC2020 · 165 citations
  2. 2Prognostic Significance of Absolute Lymphocyte Count/Absolute Monocyte Count Ratio at Diagnosis in Patients with Multiple Myeloma2013 · 34 citations
  3. 3Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis2018 · 317 citations
  4. 4The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients2019 · 208 citations
  5. 5Increased CD4/CD8 Lymphocyte ratio predicts favourable neoadjuvant treatment response in gastric cancer: A prospective pilot study2023 · 13 citations